Life-threatening purpura and vasculitis

Dowd, 1998, Purpura, 2141 Lotti, 2003, Purpuras, 451 Le Boit, 2002, Vasculitis. The true and the near true, Am. J. Dermatopathol., 24, 267, 10.1097/00000372-200206000-00015 Jennette, 1994, Nomenclature of systemic vasculitides proposal of an international consensus conference, Arthritis Rheum., 37, 187, 10.1002/art.1780370206 Fiorentino, 2003, Cutaneous vasculitis, J. Am. Acad. Dermatol., 48, 311, 10.1067/mjd.2003.212 Scott, 1994, Classification and epidemiology of systemic vasculitis, Br. J. Rheumatol., 33, 897, 10.1093/rheumatology/33.10.897 Calabrese, 2000, Sorting out cutaneous vasculitis—a rheumatologist's perspective, Clin. Exp. Rheumatol., 18, 661 Csernok, 2000, Primary vasculitides and vasculitis confined to skin: clinical features and new pathogenic aspects, Arch. Dermatol. Res., 292, 427, 10.1007/s004030000163 Lotti, 1998, Cutaneous small vessel vasculitis, J. Am. Acad. Dermatol., 39, 667, 10.1016/S0190-9622(98)70039-8 Romagnoli, 1995, Langerhans cells and vasculitis, Int. Angiol., 14, 113 Gibson, 2001, Cutaneous vasculitis update, Dermatol. Clin., 19, 603, 10.1016/S0733-8635(05)70303-X Claudy, 1999, Coagulation and fibrinolysis in cutaneous vasculitis, Clin. Dermatol., 17, 615, 10.1016/S0738-081X(99)00081-4 Papi, 1998, Livedo vasculopathy vs. small vessel cutaneous vasculitis: cytokine and platelet P-selectin studies, Arch. Dermatol., 134, 447, 10.1001/archderm.134.4.447 Bianchi, 1999, Neuropeptides and endothelial injury in cutaneous vasculitis, Clin. Dermatol., 17, 625, 10.1016/S0738-081X(99)00083-8 Ghersetich, 1993, Gamma/delta TCR lymphocytes in cutaneous necrotizing vasculitis (CNV): a clue to the infective etiology, J. Invest. Dermatol., 100, 465 Langford, 2003, Vasculitis, J. Allergy Clin. Immunol., 111, S602, 10.1067/mai.2003.80 Sais, 1998, Prognostic factors in leucocytoclastic vasculitis: a clinicopathologic study of 160 patients, Arch. Dermatol., 134, 309, 10.1001/archderm.134.3.309 Sanchez, 1985, Clinical and histopathological spectrum of necrotizing vasculitis: report of findings in 101 cases, Arch. Dermatol., 121, 220, 10.1001/archderm.121.2.220 Helander, 1995, Henoch-Schonlein purpura. Clinicopathologic correlation of cutaneous vascular IgA deposits and the relationship to leucocytoclastic vasculitis, Acta Derm. Venereol., 75, 125 Gribier, 1999, The severity of histopathological changes of leucocytoclastic vasculitis is not predictive of extracutaneous involvement, Am. J. Dermatopathol., 21, 532, 10.1097/00000372-199912000-00005 Hodge, 1987, Cutaneous leukocytoclastic vasculitis: correlation of histopathological changes with clinical severity and course, J. Cutan. Pathol., 14, 279, 10.1111/j.1600-0560.1987.tb00500.x Ratnam, 1995, Idiopathic hypersensitivity vasculitis: clinicopathologic correlation of 61 cases, Int. J. Dermatol., 34, 786, 10.1111/j.1365-4362.1995.tb04398.x Ioannidou, 2002, Cutaneous small vessel vasculitis: an entity with frequent renal involvement, Arch. Dermatol., 138, 412, 10.1001/archderm.138.3.412 Fazzini, 2001, PTX3 in small vessel vasculitides, Arthritis Rheum., 44, 2841, 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6 Tsankov, 1999, Topical modalities for the treatment of cutaneous vasculitis, Clin. Dermatol., 17, 649, 10.1016/S0738-081X(99)00085-1 Atzori, 1999, Less common treatment in cutaneous vasculitis, Clin. Dermatol., 17, 641, 10.1016/S0738-081X(99)00068-1 Vena, 1999, Immunosuppressive therapy in cutaneous vasculitis, Clin. Dermatol., 17, 633, 10.1016/S0738-081X(99)00084-X Tosca, 1996, Cyclosporine A in the treatment of cutaneous vasculitis: clinical and cellular effects, J. Eur. Acad. Dermatol. Venereol., 6, 135, 10.1111/j.1468-3083.1996.tb00156.x Stratigos, 1994, Cyclosporine A therapy for allergic cutaneous vasculitis with multiple recurrences, J. Derm. Treat., 5, 93, 10.3109/09546639409084539 Zachariae, 1995, Cyclosporine A in cutaneous vasculitis and pyoderma gangrenosum, J. Eur. Acad. Dermatol. Venereol., 5, 87, 10.1016/0926-9959(95)96094-O Jayne, 1991, Treatment of systemic vasculitis with pooled intravenous immunoglobulin, Lancet, 337, 1137, 10.1016/0140-6736(91)92797-6 Mounthon, 1996, Mechanisms of action of intravenous immune globulin in immune-mediated diseases, Clin. Exp. Immunol., 104, 3, 10.1111/cei.1996.104.s1.3 Turner, 1990, Plasma exchange in refractory cutaneous vasculitis, Br. J. Dermatol., 122, 411, 10.1111/j.1365-2133.1990.tb08291.x Wysenbeek, 1982, Limited plasmapheresis in fulminant leucocytoclastic vasculitis, J. Rheumatol., 9, 315 Lockwood, 1993, Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy, Lancet, 341, 1620, 10.1016/0140-6736(93)90759-A Mathieson, 1990, Monoclonal antibody therapy in systemic vasculitis, N. Engl. J. Med., 323, 250, 10.1056/NEJM199007263230407 Szer, 1994, Henoch Schonlein purpura, Curr. Opin. Rheumatol., 6, 25, 10.1097/00002281-199401000-00005 Sundel, 2002, Vasculitis in childhood, Rheum. Dis. Clin. North Am., 28, 625, 10.1016/S0889-857X(02)00008-X Raimer, 1992, Vasculitis in children, Semin. Dermatol., 11, 49 Nussinovitch, 1998, Cutaneous manifestations of Henoch Schonlein purpura in young children, Pediatr. Dermatol., 15, 426, 10.1046/j.1525-1470.1998.1998015426.x Tomomasa, 1987, Endoscopic findings in pediatric patients with Henoch Schonlein purpura and gastrointestinal symptoms, J. Pediatr. Gastroenterol. Nutr., 6, 725, 10.1097/00005176-198709000-00012 Saulsbury, 1984, Henoch Schonlein purpura, Pediatr. Dermatol., 1, 195, 10.1111/j.1525-1470.1984.tb01115.x Stone, 2001, Vasculitis. A collection of pearls and myths, Rheum. Dis. Clin. North Am., 4, 677, 10.1016/S0889-857X(05)70231-3 Salman, 2002, Vascular reactions in children, Clin. Dermatol., 20, 11, 10.1016/S0738-081X(01)00231-0 Ansell, 1999, Cutaneous vasculitis in children, Clin. Dermatol., 17, 577, 10.1016/S0738-081X(99)00077-2 Olson, 1992, Pulmonary disease with hemorrhage in Henoch Schonlein purpura, Pediatrics, 89, 1177, 10.1542/peds.89.6.1177 Belman, 1985, Neurologic manifestations of Henoch Schonlein purpura: report of three cases and review of the literature, Pediatrics, 75, 687, 10.1542/peds.75.4.687 Muller, 2000, Early tubular proteinuria and the development of nephritis in Henich Scholein purpura, Pediatr. Nephrol., 15, 85, 10.1007/s004670000403 Mollica, 1982, Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura, Eur. J. Pediatr., 151, 140, 10.1007/BF01958961 Saulsbury, 1993, Corticosteroid therapy does not prevent nephritis in Henoch Schonlein purpura, Pedriatr. Nephrol., 7, 69, 10.1007/BF00861574 Iijima, 1998, Multiple combined therapy for severe Henoch Schonlein nephritis in children, Pediatr. Nephrol., 12, 244, 10.1007/s004670050447 Foster, 2000, Effective therapy for severe Henoch Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study, J. Pediatr., 136, 370, 10.1067/mpd.2000.103448 Stone, 2001, Essential cutaneous vasculitis: what every rheumatologist should know about vasculitis of the skin, Curr. Opin. Rheumatol., 13, 23, 10.1097/00002281-200101000-00005 Davis, 1998, Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis, J. Am. Acad. Dermatol., 38, 899 Mehregan, 1992, Urticarial vasculitis: a histopathologic and clinical review of 72 cases, J. Am. Acad. Dermatol., 26, 441, 10.1016/0190-9622(92)70069-R Wisnieski, 2000, Urticarial vasculitis, Curr. Opin. Rheumatol., 12, 24, 10.1097/00002281-200001000-00005 Wisnieski, 1989, Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome, Arthritis Rheum., 32, 1119, 10.1002/anr.1780320910 Wisnieski, 1995, Hypocomplementemic vasculitis. Clinical and serologic findings in 18 patients, Medicine, 74, 24, 10.1097/00005792-199501000-00003 Paira, 1994, Bilateral pleural effusion in a patient with urticarial vasculitis, Clin. Rheumatol., 13, 504, 10.1007/BF02242952 Martin, 1994, Hypocomplementemic urticarial vasculitis syndrome with severe systemic manifestations, J. Pediatr., 124, 742, 10.1016/S0022-3476(05)81367-8 Asherson, 1991, Urticarial vasculitis in a connective tissue disease clinic: patterns, presentations and treatment, Semin. Arthritis Rheum., 20, 285, 10.1016/0049-0172(91)90029-Y Worm, 2000, Mycophenolate mofetil is effective for maintenance therapy of hypocomplementemic urticarial vasculitis, Br. J. Dermatol., 143, 1324, 10.1046/j.1365-2133.2000.03913.x Lamprecht, 1999, Cryoglobulinaemic vasculitis, Arthritis Rheum., 42, 2507, 10.1002/1529-0131(199912)42:12<2507::AID-ANR2>3.0.CO;2-# Jackson, 2002, Hepatitis C and the skin, Dermatol. Clin., 20, 449, 10.1016/S0733-8635(02)00013-X Agnello, 1996, Mixed cryoglobulinemia secondary to hepatitis C virus infection, Rheum. Dis. Clin. North Am., 22, 1, 10.1016/S0889-857X(05)70259-3 Ferri, 1993, Interferon alpha in mixed cryoglobulinemia patients: a randomized cross-over controlled trial, Blood, 81, 1132, 10.1182/blood.V81.5.1132.1132 Camma, 1999, Chronic hepatitis C: interferon treatment of relapsers. A meta-analysis of individual patient data, Hepatology, 30, 801, 10.1002/hep.510300329 Brillanti, 1999, Pilot study of triple anti-viral therapy for chronic hepatitis C in interferon A non-responders, Ital. J. Gastroenterol. Hepatol., 31, 130 O Hehir, 1994, Natural interferon alpha versus its combination with methyl-prednisolone in the therapy of type-II mixed cryoglobulinemia: a long term randomized, controlled study, Blood, 84, 2733 Vassilopoulos, 2002, Hepatitis C virus infection and vasculitis: implications of anti-viral and immunosuppressive therapies, Arthritis Rheum., 46, 585, 10.1002/art.10107 Stone, 2002, Polyarteritis nodosa, JAMA, 288, 1632, 10.1001/jama.288.13.1632 Guillevin, 1995, Polyarteritis nodosa related to hepatitis B virus: a prospective study with long-term observation of 41 patients, Medicine, 74, 238, 10.1097/00005792-199509000-00002 Guillevin, 2002, Polyarteritis nodosa and microscopic polyangitis, 300 Levine, 2002, Gastrointestinal involvement in polyarteritis nodosa (1986-2000) presentation and outcomes in 24 patients, Am. J. Med., 112, 386, 10.1016/S0002-9343(01)01131-7 Schader, 1985, The heart in polyarteritis nodosa: a clinicopathological study, Am. Heart J., 109, 1353, 10.1016/0002-8703(85)90365-5 Daoud, 1997, Cutaneous periarteritis nodosa: a clinicopathological study of 79 cases, Br. J. Dermatol., 136, 706, 10.1111/j.1365-2133.1997.tb03656.x Guillevin, 1996, Prognostic factors in polyarteritis nodosa and Churg Strauss syndrome. A prospective study in 342 patients, Medicine, 75, 17, 10.1097/00005792-199601000-00003 Guillevin, 1995, Polyarteritis nodosa and microscopic polyangitis, Clin. Exp. Immunol., 101, 22, 10.1111/j.1365-2249.1995.tb06157.x Gayraud, 2001, Long term follow up of polyarteritis nodosa. Microscopic polyangitis, and Churg Strauss syndrome: analysis of four prospective trials including 278 patients, Arthritis Rheum., 44, 666, 10.1002/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A Hoffman, 1998, Antineutrophil cytoplasmic antibodies, Arthritis Rheum., 41, 1521, 10.1002/1529-0131(199809)41:9<1521::AID-ART2>3.0.CO;2-A Guillevin, 1998, Treatment of polyarteritis nodosa and microscopic polyangitis, Arthritis Rheum., 41, 2100, 10.1002/1529-0131(199812)41:12<2100::AID-ART3>3.0.CO;2-J Kroiss, 2001, Transient and partial effect of high-dose intravenous immunoglobulin in polyarteritis nodosa, Dermatology, 203, 188, 10.1159/000051741 Guillevin, 1993, Treatment of polyarteritis nodosa related to hepatitis B with short term therapy with anti-viral agents and plasma exchanges. A prospective trial in 33 patients, J. Rheumatol., 30, 289 Ernhart, 2000, Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha interferon and lamivudin, J. Hepatol., 33, 677, 10.1034/j.1600-0641.2000.033004677.x Maclachlan, 2000, Successful treatment of hepatitis B associated polyarteritis nodosa with a combination of lamivudin and conventional immunosuppressive therapy: a case report, Rheumatology, 39, 106, 10.1093/rheumatology/39.1.106 Wicki, 1999, Successful treatment of polyarteritis nodosa related to hepatitis B virus with a combination of lamivudine and interferon alpha, Rheumatology, 38, 183, 10.1093/rheumatology/38.2.183 Ginarte, 1998, Cutaneous polyarteritis nodosa in a child, Pediatr. Dermatol., 15, 103, 10.1046/j.1525-1470.1998.1998015103.x Bauza, 2002, Cutaneous polyarteritis nodosa, Br. J. Dermatol., 146, 694, 10.1046/j.1365-2133.2002.04624.x Russel, 2001, Are antineutrophil cytoplasmic antibodies pathogenic?, Rheum. Dis. Clin. North Am., 27, 815, 10.1016/S0889-857X(05)70237-4 Brons, 2001, Are antineutrophil cytoplasmic antibody–associated vasculitides pauci-immune?, Rheum. Dis. Clin. North Am., 27, 833, 10.1016/S0889-857X(05)70238-6 Wiik, 2001, Clinical use of serological tests for antineutrophil cytoplasmic antibodies, Rheum. Dis. Clin. North Am., 27, 799, 10.1016/S0889-857X(05)70236-2 Savage, 2000, ABC of arterial and vascular disease. Vasculitis, BMJ, 320, 1325, 10.1136/bmj.320.7245.1325 Scott, 2000, Systemic vasculitis: epidemiology, classification and environmental factors, Ann. Rheum. Dis., 59, 161, 10.1136/ard.59.3.161 Hoffman, 1992, Wegener's granulomatosis: an analysis of 158 patients, Ann. Intern. Med., 116, 488, 10.7326/0003-4819-116-6-488 Reinhold-Keller, 2000, An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long term outcome in 155 patients, Arthritis Rheum., 43, 1021, 10.1002/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J Homer, 1998, Antineutrophilic cytoplasmic antibodies as markers for systemic autoimmune disease, Clin. Chest Med., 19, 627, 10.1016/S0272-5231(05)70107-6 Falk, 1996, Prognostic markers in patients with ANCA-associated macroscopic polyangitis and glomerulonephritis, J. Am. Soc. Nephrol., 7, 23, 10.1681/ASN.V7123 Franssen, 2000, Anti-proteinase 3 and antimyeloperoxidase associated vasculitis, Kidney Int., 57, 2195, 10.1046/j.1523-1755.2000.00080.x Regan, 2001, Treatment of Wegener's granulomatosis, Rheum. Dis. Clin. North Am., 27, 863, 10.1016/S0889-857X(05)70240-4 Haubitz, 1998, Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody associated vasculitis and renal involvement, Arthritis Rheum., 41, 1835, 10.1002/1529-0131(199810)41:10<1835::AID-ART16>3.0.CO;2-Q Jayne, 2001, Update on the European Vasculitis Study Group trials, Curr. Opin. Rheumatol., 13, 48, 10.1097/00002281-200101000-00008 DeGroot, 1998, Induction of remission in Wegener's granulomatosis with low dose methotrexate, J. Rheumatol., 25, 492 Langford, 2000, Use of methotrexate and glucocorticoids in the treatment of Wegener's granulomatosis. Long term renal outcome in patients with glomerulonephritis, Arthritis Rheum., 43, 1836, 10.1002/1529-0131(200008)43:8<1836::AID-ANR20>3.0.CO;2-R Sneller, 1995, An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone, Arthritis Rheum., 38, 608, 10.1002/art.1780380505 Stone, 1999, Treatment of non-life threatening Wegener's granulomatosis with methotrexate and daily prednisone as the initial therapy of choice, J. Rheumatol., 26, 1134 Jayne, 1999, Randomised trial of cyclophosphamide versus azathioprine during remission in ANCA-associated vasculitis (CYCAZAREM), J. Am. Soc. Nephrol., 10, 105A Luqmani, 1999, A multicenter randomised trial of cyclophosphamide versus azathioprine during remission in ANCA associated systemic vasculitis (CYCAZAREM), Arthritis Rheum., 42, S225 Langford, 1999, A staged approach to the treatment of Wegener's granulomatosis, Arthritis Rheum., 42, 2666, 10.1002/1529-0131(199912)42:12<2666::AID-ANR24>3.0.CO;2-E Metzler, 1999, Maintenance of remission with leflunomide in Wegener's granulomatosis, Arthritis Rheum., 42, S315 Jayne, 2000, Intravenous immunoglobulin for ANCA associated systemic vasculitis with persistent disease activity, QJM, 93, 433, 10.1093/qjmed/93.7.433 Stone, 2001, Etanercept combined with conventional treatment in Wegener's granulomatosis, Arthritis Rheum., 44, 1149, 10.1002/1529-0131(200105)44:5<1149::AID-ANR197>3.0.CO;2-F Drage, 2002, Evidence for pathogenic involvement of eosinophils and neutrophils in Churg-Strauss syndrome, J. Am. Acad. Dermatol., 47, 209, 10.1067/mjd.2002.124600 Masi, 1990, The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angitis), Arthritis Rheum., 33, 1094, 10.1002/art.1780330806 Lanham, 1984, Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg Strauss syndrome, Medicine, 63, 65, 10.1097/00005792-198403000-00001 Davis, 1997, Cutaneous manifestations of Churg Strauss syndrome: a clinicopathologic correlation, J. Am. Acad. Dermatol., 37, 199, 10.1016/S0190-9622(97)80125-9 Giullevin, 1999, Churg Strauss syndrome: clinical study and long term follow up of 96 patients, Medicine, 78, 26, 10.1097/00005792-199901000-00003 Clutterbuck, 1990, Renal involvement in Churg Strauss syndrome, Nephrol. Dial. Transplant., 5, 161, 10.1093/ndt/5.3.161 Termeer, 2001, Low dose interferon alpha-2b for the treatment of Churg Strauss syndrome with prominent skin involvement, Arch. Dermatol., 137, 136 Tatsis, 1998, Interferon-alpha treatment of four patients with the Churg Strauss syndrome, Ann. Intern. Med., 129, 370, 10.7326/0003-4819-129-5-199809010-00004 Gonzalez-Gay, 2001, Epidemiology of the vasculitides, Rheum. Dis. Clin. North Am., 27, 729, 10.1016/S0889-857X(05)70232-5 Kujpers, 1999, Kawasaki disease: a maturational defect in immune responsiveness, J. Infect. Dis., 18, 1869, 10.1086/315111 Huang, 2000, Polymorphism of the transmembrane region of MICA gene and Kawasaki disease, Exp. Clin. Immunogenet., 17, 364, 10.1159/000019132 Yanagawa, 1999, Effects of gamma globulin on the cardiac sequelae of Kawasaki disease, Pediatr. Cardiol., 20, 248, 10.1007/s002469900458 Newburger, 1991, A single infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome, N. Engl. J. Med., 324, 1633, 10.1056/NEJM199106063242305 Dale, 2000, Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin, J. Pediatr., 137, 723, 10.1067/mpd.2000.108444 Sundel, 1999, Therapy of acute Kawasaki disease, 184